SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose

Alexa J. Roeder, Megan A. Koehler, Sergei Svarovsky, Paniz Jasbi, Alim Seit-Nebi, Maria J. Gonzalez-Moa, John Vanderhoof, Davis McKechnie, Baylee A. Edwards, Douglas F. Lake
doi: https://doi.org/10.1101/2022.03.03.22270812

Article Information

doi 
https://doi.org/10.1101/2022.03.03.22270812
History 
  • March 6, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Alexa J. Roeder1,
  2. Megan A. Koehler1,
  3. Sergei Svarovsky2,
  4. Paniz Jasbi3,
  5. Alim Seit-Nebi2,
  6. Maria J. Gonzalez-Moa2,
  7. John Vanderhoof1,
  8. Davis McKechnie1,
  9. Baylee A. Edwards1 and
  10. Douglas F. Lake1,#
  1. 1Arizona State University, School of Life Sciences, Tempe, AZ USA
  2. 2Sapphire/AXIM Biotechnologies, San Diego, CA USA
  3. 3Arizona State University, College of Health Solutions, Phoenix, AZ USA
  1. ↵#Address correspondence to Douglas F. Lake, douglas.lake{at}asu.edu
Back to top
Posted March 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose
Alexa J. Roeder, Megan A. Koehler, Sergei Svarovsky, Paniz Jasbi, Alim Seit-Nebi, Maria J. Gonzalez-Moa, John Vanderhoof, Davis McKechnie, Baylee A. Edwards, Douglas F. Lake
medRxiv 2022.03.03.22270812; doi: https://doi.org/10.1101/2022.03.03.22270812
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area